GlassScriptPhysician profile
Jessie L Coffey
NPI 1710493085
$880.21
in general payments reported to CMS, 2019-2025
8 companies · $675 in 2025
The $675 reported for 2025 was more than what 85% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.81 · 2023: $66.83 · 2024: $111 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $263.49 | 2025 | Neffy |
| Regeneron Healthcare Solutions, INC. | $195.00 | 2025 | Dupixent |
| Genzyme Corporation | $191.84 | 2023-2025 | |
| Optinose US, INC. | $123.60 | 2024-2025 | |
| Glaxosmithkline, LLC. | $35.56 | 2025 | Nucala |
| Genentech USA, INC. | $27.81 | 2021 | |
| Stryker Corporation | $22.20 | 2025 | Scopis Ent |
| Merck Sharp & Dohme LLC | $20.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessie Coffey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.